Oncopeptides (STO: ONCO)

Last close As at 15/12/2025

SEK5.00

−0.17 (−3.29%)

Market capitalisation

SEK1,293m

Oncopeptides is a Swedish biotech company developing peptide-drug conjugates for the treatment of hematological cancers, with a focus on relapsed or refractory multiple myeloma.

Latest Insights

Healthcare | Quickview

Oncopeptides — Targeted oncology with commercial momentum

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Sofia Heigis

    CEO

  • Henrik Bergentoft

    CFO